1. Home
  2. OLMA vs VACH Comparison

OLMA vs VACH Comparison

Compare OLMA & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • VACH
  • Stock Information
  • Founded
  • OLMA 2006
  • VACH 2023
  • Country
  • OLMA United States
  • VACH United States
  • Employees
  • OLMA N/A
  • VACH N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • VACH
  • Sector
  • OLMA Health Care
  • VACH
  • Exchange
  • OLMA Nasdaq
  • VACH NYSE
  • Market Cap
  • OLMA 383.1M
  • VACH 318.5M
  • IPO Year
  • OLMA 2020
  • VACH 2024
  • Fundamental
  • Price
  • OLMA $4.99
  • VACH $10.12
  • Analyst Decision
  • OLMA Strong Buy
  • VACH
  • Analyst Count
  • OLMA 4
  • VACH 0
  • Target Price
  • OLMA $28.33
  • VACH N/A
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • VACH 253.0
  • Earning Date
  • OLMA 03-10-2025
  • VACH 01-01-0001
  • Dividend Yield
  • OLMA N/A
  • VACH N/A
  • EPS Growth
  • OLMA N/A
  • VACH N/A
  • EPS
  • OLMA N/A
  • VACH N/A
  • Revenue
  • OLMA N/A
  • VACH N/A
  • Revenue This Year
  • OLMA N/A
  • VACH N/A
  • Revenue Next Year
  • OLMA N/A
  • VACH N/A
  • P/E Ratio
  • OLMA N/A
  • VACH N/A
  • Revenue Growth
  • OLMA N/A
  • VACH N/A
  • 52 Week Low
  • OLMA $4.60
  • VACH $9.97
  • 52 Week High
  • OLMA $16.62
  • VACH $10.25
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 38.98
  • VACH N/A
  • Support Level
  • OLMA $4.94
  • VACH N/A
  • Resistance Level
  • OLMA $5.34
  • VACH N/A
  • Average True Range (ATR)
  • OLMA 0.42
  • VACH 0.00
  • MACD
  • OLMA -0.03
  • VACH 0.00
  • Stochastic Oscillator
  • OLMA 11.39
  • VACH 0.00

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About VACH VOYAGER ACQUISITION CORP.

Voyager Acquisition Corp is a blank check company.

Share on Social Networks: